Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

N-Carbamylglutamate (Carbaglu) In The Treatment Of Hyperammonemia

NCT00843921 is registered in ClinicalTrials.gov with Mendel Tuchman as lead sponsor.

NCT NCT00843921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00843921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
N-Carbamylglutamate (Carbaglu) In The Treatment Of Hyperammonemia
Lead sponsor
Mendel Tuchman
Phase
Phase 2/3
Overall status
Unknown status
Start date
August 31, 2008
Completion date
June 30, 2020
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inborn errors of metabolism